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ABSTRACT
Background. A minority of medical centers possess a
dedicated endocrine surgery program. Here we assess the
short-term impact of a new endocrine surgery program on
institutional case volumes and ﬁnancial endpoints.
Methods. We studied all endocrine procedures performed
over a 5-year period spanning the inception of the endo-
crine surgery program at UCLA. Institutional and state-
level data on patient geographic origin, discharges for
endocrine diagnosis-related groups (DRGs), and hospital-
side charges and costs were examined.
Results. Total endocrine case volume increased 112% (264
to 559 cases annually) over the study period. The relative
increase was greater for parathyroid (56 to 196, 250%, P\
0.0001) and adrenal (11 to 31, 181%, P = 0.06) procedures
compared to thyroid procedures (317 to 442, 39%). The
endocrine case volume of nonspecialist surgeons remained
stable over the study period. Growth in referrals arose from
previously unrepresented zip codes and was associated with
an increase in the mean distance traveled for care (2006, 44
miles vs. 2009, 92 miles, P\0.01). In each DRG, UCLA
attained the top market position within one year of the pro-
gram’s inception, corresponding to an overall 27% increase
in regional market share. Total hospital charges for endo-
crine DRGs rose 161% to $14.7 million annually, while the
cost of parathyroid surgery fell 34% (P\0.001).
Conclusions. The establishment of an academic endocrine
surgery program can cause fundamental shifts in referral
patterns within a competitive, densely populated metro-
politan environment. Hospitals should consider the
inclusion of an endocrine surgery program in strategic
planning initiatives.
Endocrine surgery is a maturing specialty that encom-
passes practitioners from both general surgery and
otolaryngology backgrounds.
1–3 Ample literature exists to
support the relationship between surgeon volume and
outcomes in complex and/or uncommon procedures.
4–12
These data may underlie a national trend towards region-
alization of care for complex surgery.
13 While a growing
number of surgeons identify endocrine diseases as an area
of personal interest, a minority of medical centers possess
dedicated, multidisciplinary endocrine surgery programs.
UCLA’s multidisciplinary endocrine surgery program
was established in 2006 for the purpose of concentrating
experience regarding diseases of the thyroid, parathyroid,
and adrenal glands on a select cadre of physicians with
speciﬁc training/background in endocrine topics. We will
use the term Endocrine Surgical Unit (ESU) to refer to
subspecialty-trained surgeons within the larger program.
Since its inception, we have prospectively measured the
program’s impact on clinical, educational, and hospital
ﬁnancial outcomes. In addition to improving coordination
of care for complex diseases requiring multidisciplinary
treatment, the ESU has developed a series of clinical pro-
tocols that objectively improve quality while reducing
costs.
14 Such systems of care are likely responsible for the
superior outcomes generated by high-volume centers.
15
Herein we describe the institutional effect the endocrine
surgery program has had on surgical volume, referral pat-
terns, market share, and hospital-side costs and charges.
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Data were obtained from medical cost and billing dat-
abases available from the UCLA Medical Center Financial
Services department under IRB approval. Patient medical
record numbers were masked to protect patient privacy in
accordance with HIPAA standards. Electronic records from
over 50,000 surgical patients admitted to the UCLA
Westwood hospital between July 2002 and June 2009 (an
84-month period) were queried for endocrine-speciﬁc
procedures. Using appropriate ICD-9-CM procedure codes,
patients who received a unilateral thyroid lobectomy (ICD-
9-CM codes: 6.2, 6.31, 6.39), total thyroidectomy (ICD-9-
CM codes: 6.4, 6.51, 6.57), parathyroidectomy (ICD-9-CM
codes: 6.81, 6.89), or adrenalectomy (ICD-9-CM codes:
7.21, 7.22, 7.29, 7.3) were selected from the master ﬁle.
Cases were excluded if patient records included a diagnosis
of kidney transplantation, renal failure, or dialysis. Head
and neck operations involving non-endocrine cancers were
excluded, as were emergency operations. A subset of
more common procedures, including appendectomy, lapa-
roscopic cholecystectomy, colectomy, and hysterectomy,
were also identiﬁed using appropriate ICD-9 codes. Cost,
charges, and number of admissions for these procedures
were aggregated to create an index of global institutional
trends in surgical volumes and ﬁnancial endpoints.
Demographic data collected included age, gender, race,
ethnicity, health insurance, and ﬁve-digit zip code for pri-
mary residence. Medical information collected included
diagnoses, procedures, treatment dates, total costs and
charges. Distance traveled to UCLA was estimated by
entering residential zip codes into a mileage calculator (Zip
Code Distance Wizard, version 1.91). Data on market share
was obtained from the California Ofﬁce of Statewide
Health Planning and Development. We analyzed institu-
tional volume and ﬁnancial trends by creating a cost index
for common operations performed contemporaneously and
involving similar nursing and ancillary staff. Control
operations included laparoscopic cholecystectomy, open
appendectomy, hemi-colectomy, and total hysterectomy.
The following nonparametric tests were applied for data
analysis: Wilcoxon rank-sum test, Kruskal–Wallis test, and
contingency table tests. Data were analyzed by Stata/SE
9.2 (StataCorp, College Station, TX).
The study was conducted with the approval of the
UCLA Institutional Review Board, protocol G08-11-016-
02.
RESULTS
From July 2002 to June 2009, a total of 46,807 unique
admissions for surgical procedures occurred at UCLA
Medical Center. Of these, 2,700 individuals were admitted
for elective endocrine surgery, including 1,770 patients
who underwent operations of the thyroid, 741 patients who
underwent operations of the parathyroid glands, and 189
patients who underwent operations of the adrenal glands.
These patients comprised the ﬁnal study group. Table 1
displays the number of procedures by target organ per
ﬁscal year from 2005–2009. Total endocrine case volume
at our institution increased 112% (264 to 559 cases annu-
ally) over the study period. The relative magnitude of the
volume increase was greater for parathyroid (56 to 196,
250%, P\0.001) and adrenal (11 to 31, 181%, P = 0.06)
procedures compared to thyroid procedures (197 to 334,
39%, P\0.001). In 2006, the ﬁrst year of its existence, the
ESU performed 35 of 285 (12.3%) of all endocrine pro-
cedures at our institution. This proportion grew to 351 of
559 (62.8%) in 2009. During this period of rapid growth
within the ESU, the endocrine case volume of non-spe-
cialist surgeons within the institution remained stable,
moving in parallel with overall surgical volumes (Fig. 1).
No changes in UCLA network afﬁliations occurred during
this time period.
An examination of the residential zip codes for those
patients receiving endocrine surgical care at our institution
demonstrated a signiﬁcant increase in mean distance trav-
elled per patient following the establishment of the ESU
(2006, 44 miles vs. 2009, 92 miles, all cases, P\0.0001,
Fig. 2). The increase in travel distance was most prominent
for patients undergoing parathyroid surgery (2006, 41
miles vs. 2009, 149 miles, P\0.001) but was also sig-
niﬁcant for thyroid surgery (2006, 42 miles vs. 2009, 60
TABLE 1 Comparison of case loads of ESU versus non-ESU sur-
geons, ﬁscal years 2005–2009
2005 2006 2007 2008 2009
Total, n (%)
Non-ESU 264 (100) 250 (87.7) 228 (56.2) 187 (41.4)
208 (37.2)
ESU – 35 (12.3) 178 (43.8) 265 (58.6) 351 (62.8)
Thyroid, n (%)
Non-ESU 197 (100) 196 (91.2) 178 (67.9) 150 (55.1)
166 (50.0)
ESU – 19 (8.8) 84 (32.1) 122 (44.9) 166 (50.0)
Parathyroid, n (%)
Non-ESU 56 (100) 38 (73.1) 36 (31.3) 28 (19.9)
31 (15.8)
ESU – 14 (26.9) 79 (28.7) 113 (80.1) 165 (84.2)
Adrenal, n (%)
Non-ESU 11 (100) 16 (88.9) 14 (48.3) 9 (23.1)
11 (35.5)
ESU – 2 (11.1) 15 (51.7) 30 (76.9) 20 (64.5)
ESU Endocrine surgical unit
Strategic Impact 2261miles, P\0.05). Figure 3 features choropleth maps
showing the distributions of patient origin by zip code from
an eight-county region in Southern California (population
20 million, encompassing the following counties: Los
Angeles, Orange, Riverside, San Bernardino, Ventura,
Santa Barbara, Kern, San Luis Obispo) in 2005 and 2009.
The total number of zip codes from which at least one
patient was treated by the ESU in 2005 was 180. In 2009,
294 zip codes were represented (P\0.001). Additionally,
the number of zip codes yielding four or more patients
increased from eight in 2005 to 35 in 2009 (P\0.001).
Figure 4 shows the regional market shares of all insti-
tutions performing endocrine procedures. Over this time
period, the annual number of endocrine procedures per-
formed in the region grew 17%, from 11,251 to 13,172
procedures. Beginning with 2005, the year immediately
prior to the establishment of the ESU, UCLA held the
second-highest market share, performing 3.9% (205 of
5247) of all endocrine operations in the region. By 2007,
UCLA had achieved the top share at 6.4% (354 of 5522),
and maintained this position through 2008 with a market
share of 6.2% (341 of 5532). The slight decrease observed
from 2007 to 2008 reﬂects the fact that approximately half
of the ESU case volume was, at that time, shifted to the
outpatient setting, which is not captured in the state-level
market share data.
We identiﬁed 11 high-volume hospitals, performing 100
or more endocrine procedures annually, within the region.
The near-doubling of UCLA’s market share from 2003 to
2008 (3.2 to 6.2%) was associated with a rise in the total
proportion of cases performed by high volume hospitals
from 26.2 to 33.0% (P\0.0001).
The total costs incurred and charges billed for thyroid,
parathyroid, and adrenal procedures were collected and
adjusted to 2009 dollar values using the Consumer Price
Index calculator.
16 Annual charges for operations of the
thyroid, parathyroid, and adrenal glands in aggregate
exhibited a 161% increase from 2005 to 2009, with total
charges in 2009 reaching $14.7 million. This occurred
simultaneously with a steady decrease in the costs associ-
ated with endocrine procedures (13% reduction compared
to an index of common procedures), driven largely by a
34% decrease in the cost of parathyroid surgery per oper-
ation over the same time period (P\0.001).
DISCUSSION
The precise number of multidisciplinary endocrine sur-
gery programs in the nation is difﬁcult to determine. Our
informal survey of academic departmental websites iden-
tiﬁed 248 general surgery residency programs in the United
States. Though we found that 134 of 248 departments
(54.2%) had one or more surgical faculty members
expressing a speciﬁc interest in endocrine diseases, only 21
departments possessed dedicated endocrine centers.
Within the last decade, a growing body of literature has
documented the association between volume and outcomes
for complex surgical procedures.
5,6,8,9,11,12 Several studies
speciﬁcally examining endocrine procedures have demon-
strated that high-volume surgeons achieve the lowest
complication rates as well as shorter lengths of hospital-
ization.
4,7,13 Despite these consistent ﬁndings, the great
majority of endocrine procedures performed in the US
FIG. 1 Trends in absolute case volume of the ESU (blue line), as
compared to non-specialist surgeons (yellow line), and select common
operations (laparoscopic appendectomy, laparoscopic cholecystec-
tomy, colectomy, hysterectomy; green line); ﬁscal years 2002–2009
FIG. 2 Mean distance traveled for treatment by target organ, ﬁscal
years 2006–2009
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17 Pro-
posed explanations for this discordance include limited
opportunities for subspecialty training in endocrine surgery
as well as limited patient access to high-volume surgeons,
given their sporadic geographic distribution.
2
Herein we have demonstrated in a prospective fashion
that a newly established ESU can alter regional patterns in
the delivery of endocrine surgical care. Within a short time
frame, the ESU at UCLA concentrated a large volume of
cases from a progressively widening geographic radius.
The volume gains at this single center correlated with a
26% increase in the proportion of endocrine procedures
performed at high-volume centers within the region.
Changes of this nature are precisely those that would be
predicted to improve the quality of surgical care provided.
Indeed, we have described contemporaneous institutional
improvements in clinical outcomes (reduced complication
rates) and patient-level economic outcomes (reduced
length of stay and hospital resource utilization) related to
the growth of the ESU.
14,18
The fact that most endocrine procedures in the nation
are performed by low-volume surgeons represents an
opportunity for the establishment of additional specialty
centers. The magnitude of the volume-outcomes effect is
pronounced for certain types of endocrine procedures, such
as parathyroidectomy and thyroid cancer surgery, where
initial referral to a specialty center is likely to yield lower
complication rates and a reduced need for remedial sur-
gery.
4,19,20 We perceive that specialized endocrine surgery
centers are currently growing at a rate much slower than
that necessary to meet projected workforce needs.
2 We
propose two potential reasons for this: (1) a perception that
competition from neighboring hospitals would prohibit the
establishment of a high-volume center, and (2) concern on
the part of existing physicians within an institution that
their surgical volumes would be adversely affected by a
new specialty center. Indeed, we were motivated to present
our data in order to debunk both of these arguments.
FIG. 3 Choropleth maps demonstrating the evolution of the distribution of zip code of origin for patients referred for surgical treatment of
endocrine disorders at UCLA, ﬁscal years 2005–2009
UCLA
FIG. 4 Distribution of market share for endocrine operations,
8-county region (Los Angeles, Orange, Riverside, San Bernardino,
Ventura, Santa Barbara, Kern), ﬁscal years 2002–2008
Strategic Impact 2263Greater Los Angeles is the second largest population
center in the United States and, according to most measures,
one of the top ten largest urban areas in the world.
21 In 2008,
13,172 endocrine procedures were performed across 208
hospitals in the region studied. Were these cases distributed
uniformly, each hospital would perform 63 procedures, well
less than the threshold required to achieve optimal out-
comes.
4 In other words, competition between hospitals
within the region would likely counteract quality improve-
ment. Our data demonstrate that intense competition from
neighboring hospitals does not necessarily impede case
volume concentration within a new specialty center.
Furthermore, the growth in volume within the ESU did
not cannibalize volume from other practitioners within our
institution. Instead, the added ESU cases appear to have
come from an expansion of the geographic territory
effectively served by the hospital for endocrine surgical
needs. This point is of particular importance because
existing practitioners are likely in a position to enable or
block recruitment of the subspecialty-trained physicians
necessary to create a new multidisciplinary endocrine
surgery program. The slight decline in overall case vol-
umes observed during 2007–2008 has been ascribed to the
global economic downturn of the period.
The establishment of the ESU has also exerted a notable
effect on average per-patient costs length of stay for
endocrine procedures. This effect was primarily driven by
two factors: the transition in 2008 of more than 90% of
parathyroid operations to an outpatient surgery center, and
the implementation of algorithm-based clinical pathways.
14
Both of these actions have liberated valuable inpatient beds
and operating rooms to serve the needs of an increasingly
complex inpatient population.
In conclusion, our data demonstrate that the establish-
ment of a dedicated endocrine surgical program at an
academic hospital can lead to fundamental shifts in insti-
tutional referral patterns, resulting in higher operative
volume. This ultimately contributes to the regionalization
of care for complex surgical problems and the redistribu-
tion of regional market share. As such, academic medical
centers should consider the establishment of a specialized
endocrine surgery program a priority in the realm of stra-
tegic planning.
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